Cel Sci Corp SEC filings CVM
Cel Sci Corp has 1,007 filings in SEC EDGAR's recent list, going back to Jun 12, 2012. Its latest annual report, Form ARS, was filed on Jul 2, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 17, 2026 (shareholder vote results). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 3, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Aug 17, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| ARS | Annual report to shareholders | Jul 2, 2026 | Sep 30, 2025 |
| DEF 14A | Proxy statement | Jul 2, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 16, 2026 | Jun 14, 2026 |
| 424B5 | Prospectus supplement | Jun 15, 2026 | — |
| RW | Form rw | May 27, 2026 | — |
| RW | Form rw | May 19, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
May 14, 2026 | May 11, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
May 13, 2026 | May 11, 2026 |
| 424B4 | Prospectus | May 13, 2026 | — |
| EFFECT | Filing | May 11, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| S-1/A | Amended registration statement | May 1, 2026 | — |
| DEL AM | Filing | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 20, 2026 | — |
| S-1 | Registration statement | Apr 17, 2026 | — |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Dec 29, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Dec 3, 2025 | — |
| CORRESP | Letter to the SEC | Dec 1, 2025 | — |
| 8-K |
Current report
Change to shareholder rights
|
Nov 24, 2025 | Nov 18, 2025 |
| S-3 | Shelf registration | Nov 7, 2025 | — |
| 8-K |
Current report
Change to shareholder rights
|
Nov 5, 2025 | Oct 30, 2025 |
| S-8 | Employee stock plan registration | Aug 29, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Aug 29, 2025 | Aug 27, 2025 |
| 424B5 | Prospectus supplement | Aug 28, 2025 | — |
| 424B5 | Prospectus supplement | Aug 27, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 25, 2025 | Aug 22, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| EFFECT | Filing | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 7, 2025 | — |
| S-3/A | Form s-3 | Aug 5, 2025 | — |
| CORRESP | Letter to the SEC | Aug 5, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| DRS | Filing | Jul 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 14, 2025 | Jul 11, 2025 |
| 424B5 | Prospectus supplement | Jul 14, 2025 | — |
| S-3 | Shelf registration | Jul 3, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
May 23, 2025 | May 21, 2025 |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| 424B5 | Prospectus supplement | May 21, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 19, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Mar 31, 2025 |
| DEF 14A | Proxy statement | Apr 9, 2025 | Mar 31, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 21, 2025 | Mar 12, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Mar 18, 2025 | Mar 17, 2025 |
| 424B5 | Prospectus supplement | Mar 18, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2025 | — |
| CORRESP | Letter to the SEC | Mar 3, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2025 | — |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Jan 13, 2025 | Sep 30, 2024 |
| 424B3 | Prospectus | Jan 3, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 31, 2024 | Dec 29, 2024 |
| 424B5 | Prospectus supplement | Dec 30, 2024 | — |
| NT 10-K | Filing | Dec 30, 2024 | Sep 30, 2024 |
| 424B5 | Prospectus supplement | Dec 27, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 12, 2024 |
| EFFECT | Filing | Nov 7, 2024 | — |
| CORRESP | Letter to the SEC | Nov 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| S-3/A | Form s-3 | Oct 30, 2024 | — |
| S-3 | Shelf registration | Oct 25, 2024 | — |
| POS AM | Filing | Oct 11, 2024 | — |
| AW | Filing | Oct 10, 2024 | — |
| S-3/A | Filing | Oct 8, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 17, 2024 | Sep 16, 2024 |
| S-8 | Employee stock plan registration | Aug 30, 2024 | — |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 29, 2024 | Jul 26, 2024 |
| 424B5 | Prospectus supplement | Jul 29, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 20, 2024 | Jun 18, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2024 | Apr 19, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Apr 19, 2024 | Apr 19, 2024 |
| DEFA14A | Additional proxy material | Mar 7, 2024 | — |
| ARS | Annual report to shareholders | Mar 7, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Mar 7, 2024 | Mar 1, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 13, 2024 | Feb 8, 2024 |
| 424B5 | Prospectus supplement | Feb 9, 2024 | — |
| S-8 | Employee stock plan registration | Dec 22, 2023 | — |
| 10-K | Annual report | Dec 21, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2023 | Nov 15, 2023 |
| 424B5 | Prospectus supplement | Nov 16, 2023 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Oct 30, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Other events
|
Oct 24, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 31, 2023 | Aug 28, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Other events
|
Jul 20, 2023 | Jul 20, 2023 |
| 424B5 | Prospectus supplement | Jul 18, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 18, 2023 | Jul 17, 2023 |
| FWP | Free writing prospectus | Jul 17, 2023 | — |
| 424B5 | Prospectus supplement | Jul 17, 2023 | — |
| 8-K |
Current report
Other events
|
Jul 14, 2023 | Jul 14, 2023 |
| 8-K |
Current report
Other events
|
Jul 12, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
May 1, 2023 | Apr 27, 2023 |
| 424B5 | Prospectus supplement | May 1, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 19, 2023 | Apr 19, 2023 |
| DEFA14A | Additional proxy material | Apr 10, 2023 | — |
| ARS | Annual report to shareholders | Apr 10, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 10, 2023 | May 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 9, 2023 | Mar 8, 2023 |
| 10-Q | Quarterly report | Feb 14, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Dec 27, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Sep 13, 2022 | Sep 12, 2022 |
| 8-K |
Current report
Other events
|
Aug 22, 2022 | Aug 19, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 8, 2022 | Aug 2, 2022 |
| EFFECT | Filing | Jul 15, 2022 | — |
| EFFECT | Filing | Jul 15, 2022 | — |
| CORRESP | Letter to the SEC | Jul 13, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2022 | — |
| S-3 | Shelf registration | Jul 1, 2022 | — |
| POS AM | Filing | Jul 1, 2022 | — |
| S-8 | Employee stock plan registration | Jul 1, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2022 | Jun 13, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| ARS | Annual report to shareholders | Apr 29, 2022 | Dec 31, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 13, 2022 |
| 10-Q | Quarterly report | Feb 11, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Dec 21, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 13, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Jul 7, 2021 | Jul 7, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2021 | Jul 1, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 29, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 28, 2021 | Jun 23, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 9, 2021 | Jun 8, 2021 |
| 424B5 | Prospectus supplement | Jun 9, 2021 | — |
| FWP | Free writing prospectus | Jun 9, 2021 | — |
| 424B5 | Prospectus supplement | Jun 9, 2021 | — |
| DEFA14A | Additional proxy material | May 18, 2021 | — |
| ARS | Annual report to shareholders | May 18, 2021 | Dec 31, 2020 |
| DEF 14A | Proxy statement | May 18, 2021 | Jul 1, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Feb 12, 2021 | Dec 31, 2020 |
| EFFECT | Filing | Jan 25, 2021 | — |
| POS AM | Amendment no 4 | Jan 15, 2021 | — |
| 10-Q/A | Amended quarterly report | Dec 31, 2020 | Jun 30, 2020 |
| 10-Q/A | Amended quarterly report | Dec 30, 2020 | Mar 31, 2020 |
| 10-Q/A | Amended quarterly report | Dec 30, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Dec 29, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Restatement
|
Dec 29, 2020 | Dec 23, 2020 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 9, 2020 | Dec 8, 2020 |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| FWP | Free writing prospectus | Dec 9, 2020 | — |
| 424B5 | Prospectus supplement | Dec 9, 2020 | — |
| 8-K |
Current report
Other events
|
Dec 8, 2020 | Dec 7, 2020 |
| 8-K |
Current report
Change to shareholder rights
|
Oct 30, 2020 | Oct 30, 2020 |
| 10-Q/A | Amended quarterly report | Aug 11, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| EFFECT | Filing | Jul 10, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2020 | — |
| CORRESP | Letter to the SEC | Jul 8, 2020 | — |
| S-1 | Registration statement | Jul 2, 2020 | — |
| 8-K |
Current report
Unregistered share sale
|
Jul 1, 2020 | Jun 25, 2020 |
| 424B3 | Prospectus | May 26, 2020 | — |
| 8-K |
Current report
Change to shareholder rights
|
May 26, 2020 | May 26, 2020 |
| 10-Q | Quarterly report | May 8, 2020 | Mar 31, 2020 |
| S-8 | Employee stock plan registration | Apr 24, 2020 | — |
| EFFECT | Filing | Apr 20, 2020 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 17, 2020 | Apr 17, 2020 |
| CORRESP | Letter to the SEC | Apr 15, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2020 | — |
| S-1 | Registration statement | Apr 9, 2020 | — |
| DEFA14A | Additional proxy material | Mar 30, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 24, 2020 | Mar 23, 2020 |
| 424B5 | Prospectus supplement | Mar 24, 2020 | — |
| FWP | Free writing prospectus | Mar 24, 2020 | — |
| FWP | Free writing prospectus | Mar 24, 2020 | — |
| 424B5 | Prospectus supplement | Mar 24, 2020 | — |
| EFFECT | Filing | Mar 18, 2020 | — |
| DEFA14A | Additional proxy material | Mar 17, 2020 | — |
| CORRESP | Letter to the SEC | Mar 16, 2020 | — |
| POS AM | Filing | Mar 13, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2020 | — |
| CORRESP | Letter to the SEC | Mar 9, 2020 | — |
| POS AM | Filing | Mar 6, 2020 | — |
| CORRESP | Letter to the SEC | Mar 4, 2020 | — |
| DEFA14A | Additional proxy material | Mar 4, 2020 | — |
| ARS | Annual report to shareholders | Mar 4, 2020 | Dec 31, 2019 |
| DEF 14A | Proxy statement | Mar 4, 2020 | Apr 17, 2020 |
| UPLOAD | Letter from the SEC | Mar 4, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CVM (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- CO
- Headquarters
- Vienna, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 725363
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.